Cell Fate in Cancer

The cell is the basic unit of life. The attainment of a nucleus to house the genetic material is thought to have provided a distinct advantage to the evolving cell, ultimately allowing the emergence of differentiated, specialized cells.  Hoarding evidence suggests that genomes are organized non-randomly into complex 3D configurations that vary according to cell type, stage of development, differentiation and disease status. The principles, which guide higher order organization, the mechanisms responsible for establishment, maintenance and alterations of higher order genome, and the functional consequences of aberrant genome and nuclear organization, have become zones of intense interest. The higher-order spatial and temporal organization of genomes in the cell nucleus is rapidly evolving as a driver of biological function in differentiation, development and disease and the incorporation of information on higher order genome organization add an additional level of complexity in our understanding of genome regulation.  DNA sequence variations and biochemical sequence modifications co-define cell fate. Through exploration of cancer genomes, new gene categories have been identified that imply novel underlying mechanisms related to epigenetics, transcriptional processes and cell differentiation. These contrivances are of major prominence in tumorigenesis and cancer therapy failure.

Differentiated tumor cells may present different elevated cell potencies. Thus, tumor heterogeneity may be presented as a certain three-dimensional space that is defined by the range of three key features – cell potency, cell lineage specificity and variance. Cell fate dynamics and the resulting cell population diversity and evolution during tumorigenesis and cancer drug treatment have been correlated with cellular responses to environmental stress. This might provide new insights for understanding tumorigenesis and new strategies that target whole cell system dynamics for cancer therapy.

  • Oncoproteins and Cellular Targets
  • Emerging Concepts and Technologies
  • Genomics, Biomarkers and clinical trials
  • Integrative Science and Translation

Related Conference of Cell Fate in Cancer

Ljubljana Slovenia

ESSO-EYSAC Course on Colorectal Cancer Surgery Ljubljana Slovenia

21st to 23rd January 2016
Miami Florida United States of America

Miami 2016 Winter Symposium Miami United States of America

24th to 27th January 2016
Penang Malaysia

2nd AMDI International Biohealth Sciences Conference 2016 Penang Malaysia

26th to 28th January 2016
Berlin Germany

ESSO Course on the Management of High Risk Patients for Breast Cancer A Multidisciplinary Approach Berlin Germany

5th to 6th February 2016
Pune Maharashtra India

3rd International Conference on Biotechnology and Bioinformatics ICBB-2016 Pune India

5th to 7th February 2016
Hyderabad Telangana India

New and Emerging Trends In Oncology 2016 Hyderabad India

10th to 12th February 2016
Mumbai India

International Conference on Radiation Research Impact on Human Health and Environment Mumbai India

11th to 13th February 2016
Singapore

3rd Annual International Conference on Advances in Cancer Medical Research ACMR 2016 Singapore Singapore

22nd to 23rd February 2016
Kuala Lumpur Malaysia

The Probiotics Congress Asia Kuala Lumpur Malaysia

29th February to 1st March 2016
San Francisco CA United States of America

Molecular Medicine Tri-Con 2016 San Francisco United States of America

6th to 11th March 2016

Cell Fate in Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in